Sign Up to like & get
recommendations!
0
Published in 2020 at "Chest"
DOI: 10.1016/j.chest.2020.11.011
Abstract: BACKGROUND Clinical heterogeneity in bronchiectasis remains a challenge to improve the appropriate targeting of therapies and patient management. Antimicrobial peptides (AMPs) have been linked to disease severity and phenotype. RESEARCH QUESTION Can we identify clusters…
read more here.
Keywords:
patients based;
tissue remodeling;
bronchiectasis;
remodeling damage ... See more keywords